New Guidelines for Head & Neck Cancer Reirradiation

New Guidelines for Head & Neck Cancer Reirradiation | Feature

August 16, 2012

Recurrent and second primary head-and-neck squamous cell carcinomas arising within or close to previously irradiated areas are a significant clinical challenge. The American College of Radiology published appropriateness criteria for recurrent head and neck cancer after prior definitive radiation.

Agent Approved for Highly Toxic Chemotherapy Levels | News Brief

March 20, 2012

The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that the body is able to eliminate.

Source: FDA newsroom.…

A New Guide for Using Antiemetics | Feature

March 13, 2012

A significant proportion of all cancer patients experience nausea or vomiting during the course of their treatment. Nausea and vomiting have long been common adverse effects from certain types of cancer therapy and can lead to postponement or refusal of potentially curative treatments in some patients.…

The Impact of Complications on Colorectal Cancer Care | Opinion Article

September 5, 2011

Although the use of adjuvant chemotherapy has been a key quality measure for stage III CRC care because it’s associated with a significant survival benefit, national data indicate that guideline-recommended care is not provided to many patients.

The Burden of Pain & Depression in Cancer Patients | Feature

March 15, 2011

Patients with cancer who experience pain or depression have many types of symptoms. Clinicians should make efforts to recognize and manage somatic symptoms to improve quality of life and function in these patients, regardless of type or phase of cancer.

Oncology Update 2011 | eMedia

January 22, 2011

A collection of interview-based articles by leading experts in oncology.…

Good Nutrition Critical to Chemotherapy | Opinion Article

January 17, 2011

Targeted therapies and advances in genetics are enabling more personalized patient care for several cancer types. However, treating cancer patients goes beyond the cancer itself; clinicians need to treat the whole patient. Nutrition is an often overlooked element of care.